Participate in the CREDENCE study on type 2 diabetes and kidney health (Melbourne) 10 December 2014 Do you have type 2 diabetes? Do you have problems with your kidneys? If the answer to both questions is Yes, you may be able to take part in a clinical research study. The CREDENCEtm Study is looking at an investigational (study) medication (taken as a daily capsule) that may help protect the kidneys in people with type 2 diabetes. They are looking for people who: Are 30 years of age or older Have a diagnosis of type 2 diabetes Have kidney problems related to their diabetes Are currently taking medicines to control their kidney problems? If you choose to take part in the CREDENCEtm Study, you will be looked after by an experienced study team who will carefully monitor your health and support your diabetes management. You will continue to take your current diabetes medications. For more information please contact: Nicky Robinson on 9496 2645 or Clinical [email protected] This study has been approved by the Austin Health Human Research Ethics Committee. HREC: 28431754DNE3001
Media releases 19 August 2026 Wearable non-invasive continuous glucose monitor leads innovation challenge Xoma Labs has been named the Grand Innovation Challenge winner, following a nationwide search for innovative technologies to transform the lives of people living with diabetes. Continue Reading
Media releases 18 August 2026 500k Shane Warne Legacy Health Check milestone on the first day of international diabetes congress The Western-Pacific’s largest diabetes and metabolic health congress has opened with a Community Day in Melbourne, delivering the 500,000th Shane Warne Legacy health check to highlight the importance of cardiometabolic health screenings, and the urgent nature of the type 2 diabetes epidemic facing the region. Continue Reading
Media releases 17 August 2026 Diabetes Australia to deliver Insulin Pump Program supporting children and young people Diabetes Australia has been appointed to deliver the Commonwealth-funded Insulin Pump Program (IPP). Continue Reading